知镜 Cognispect · 医学文献与研究工作台

Hydrus ® Microstent Combined with Cataract Surgery in Pseudoexfoliation Glaucoma Versus Primary Open Angle Glaucoma.

Keidel LF, Engelmann C, Hafner M, Gehrke M, Buhl L, Priglinger SG, Mackert MJ.
Journal of clinical medicine · 2026-09-11 · PMID 42795811

文献摘要

Background/Objectives: Our objective was to compare clinical outcomes of the Hydrus ® Microstent implantation combined with cataract surgery in eyes with pseudoexfoliation glaucoma (PXG) and primary open angle glaucoma (POAG). Methods: This retrospective, single-center comparative cohort study included eyes with POAG or PXG undergoing combined cataract surgery and Hydrus ® Microstent implantation between June 2021 and December 2025 at the University Eye Hospital of the Ludwig Maximilian University in Munich, Germany. Clinical outcomes were evaluated until 8-14 months after surgery. Results : A total of 74 eyes were included, comprising 49 POAG eyes and 25 PXG eyes. After cataract surgery plus Hydrus ® Microstent, IOP decreased significantly in both groups from baseline to the final 8-14-month follow-up (POAG: 17.6 ± 3.9 to 13.8 ± 2.3 mmHg, p p p = 0.410). Meanwhile, the number of IOP-lowering medications decreased significantly in both groups with no between-group difference (POAG: -1.20 medications; PXG group -1.09 medications, p = 0.724). Surgical success rates were comparable. Conclusions : Hydrus ® Microstent implantation combined with cataract surgery showed comparable surgical outcomes in POAG and PXG eyes. Regardless of the more aggressive disease characteristics of PXG, no significant differences were observed between PXG and POAG eyes regarding IOP reduction, medication burden, BCVA, surgical success, complications or safety outcomes. These findings suggest that combined cataract surgery and Hydrus ® Microstent implantation may be a useful treatment option in selected patients with PXG.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。